Showing results (21-30 of 52) with videos related to
Sort By:
Pageof 6
Angewandte Chemie (International Ed. in English)|September 9, 2016
Deorphaning the Macromolecular Targets of the Natural Anticancer Compound DoliculideGisbert Schneider, Daniel Reker, Tao Chen, et al.Trends in Molecular Medicine|September 24, 2013
Common non-epigenetic drugs as epigenetic modulatorsJörn Lötsch, Gisbert Schneider, Daniel Reker, et al.Journal of Immunological Methods|September 24, 2013
Validated detection of anti-GD2 antibody ch14.18/CHO in serum of neuroblastoma patients using anti-idiotype antibody ganglidiomabNikolai Siebert, Diana Seidel, Christin Eger, et al.Angewandte Chemie (International Ed. in English)|December 6, 2014
Multidimensional de novo design reveals 5-HT2B receptor-selective ligandsTiago Rodrigues, Nadine Hauser, Daniel Reker, et al.Nature Computational Science|February 27, 2024
Characterizing emerging companies in computational drug developmentChloe Markey, Samuel Croset, Olivia Ruth Woolley, et al.Oncotarget|November 29, 2016
New use of an old drug: inhibition of breast cancer stem cells by benztropine mesylateJihong Cui, Maija Hollmén, Lina Li, et al.Science Translational Medicine|March 15, 2019
"Inactive" ingredients in oral medicationsDaniel Reker, Steven M Blum, Christoph Steiger, et al.Angewandte Chemie (International Ed. in English)|October 22, 2015
De Novo Fragment Design for Drug Discovery and Chemical BiologyTiago Rodrigues, Daniel Reker, Martin Welin, et al.Molecular Informatics|September 22, 2016
Matrix-based Molecular Descriptors for Prospective Virtual Compound ScreeningFrancesca Grisoni, Daniel Reker, Petra Schneider, et al.ACS Nano|June 10, 2026
The Use of Deep Learning in RNA Therapeutic DevelopmentDeepak A Subramanian, Sophia L Yao, Alvin Chan, et al.Pageof 6